Published in Cancer Weekly, July 27th, 2004
The finding could help patients and doctors make the often difficult decision of whether to undergo surgery or merely wait and watch.
The PSA test is widely used to diagnose prostate cancer by measuring levels of a substance called prostate-specific antigen in the blood. Up to now, doctors have focused largely on the PSA level itself, and not on how it changes over time.
But researchers at Brigham and Women's Hospital...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.